Agouron Pharmaceuticals (AGPH) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Agouron Pharmaceuticals (AGPH)

An SI Board Since March 1996

Posts	SubjectMarks	Bans	Symbol
6136	24	0	AGPH

Emcee: Bhag Karamchandani	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
4636	Actually, looks like we need it to hold 28...if it breaks that, it could go	Steve Fancy	-	6/30/1998
4635	Hit 30 1/16...if it breaks 30, 26-27 here we come. Like it or not, AGPH is	Steve Fancy	-	6/30/1998
4634	Peter: And here's the 266 plus nelf release....... prnewswire.com Izzy..	scaram(o)uche	-	6/30/1998
4633	Yep, this continual buy on weakness strategy on this stock got me in a lot o	Steve Fancy	-	6/30/1998
4632	Re: "Looks to me like today is the day to buy AGPH." I did at 30 1	Intel Trader	-	6/30/1998
4631	CNBC just report price drops in AGPH and VRTX due to Sustiva news.	Henry Niman	-	6/30/1998
4630	There's a WSJ article plugging Sustiva today - suggests it might replace PI	Biomaven	-	6/30/1998
4629	AGPH licenses another PI. biz.yahoo.com	sam	-	6/30/1998
4628	Rick, I asked some questions about PI resistance awhile ago because thestreet.c	Henry Niman	-	6/30/1998
4627	It's a good article, not sensational as some of the press releases have bee	margie	-	6/30/1998
4626	Peter: Good stuff, thanks! Margie had told me, a couple of weeks ago, about	scaram(o)uche	-	6/30/1998
4625	>> Life cycle for any of these drugs is hard to predict- except that it	scaram(o)uche	-	6/30/1998
4624	Rick, Here's a quote from an article (Truncal Obesity, "Crix-Belly&qu	Biomaven	-	6/30/1998
4623	Life cycle for any of these drugs is hard to predict- except that it is increas	Bhag Karamchandani	-	6/30/1998
4622	Bhag, I probably shouldn't open my mouth on issues I know little about,	Steve Fancy	-	6/30/1998
4621	Sam: In one of my previous postings, I argued that most start up biotechs would	Bhag Karamchandani	-	6/30/1998
4620	Margie: prnewswire.com Not really certain what this says, but note that they	scaram(o)uche	-	6/29/1998
4619	fyi, helpful post from the Yahoo thread on the NYT gp120 article (where I found	Peter Singleton	-	6/29/1998
4618	Peter: No, no real opinion of CCR5. I follow it very, very, very closely, how	scaram(o)uche	-	6/29/1998
4617	nice article from NYT 6/18/98, on solving the structure of GP120 ... X-RAYS SH	Peter Singleton	-	6/29/1998
4616	<<With the AIDS vaccine in clinical trials and the reported potential ef	Joe E.	-	6/29/1998
4615	Rick, that was a strange release from Roche. So, they are targeting chemokine	Peter Singleton	-	6/29/1998
4614	No offense intended. I suppose that we'll see all kinds of treatment result	Izzy	-	6/29/1998
4613	Geeeze, Izzy.... Crix was used because Sustiva was the product of DuPont-Merc	scaram(o)uche	-	6/29/1998
4612	Bhag: Nah, this market cap is tiny. Johnson could double it overnight. The R	scaram(o)uche	-	6/29/1998

Go to reply# or date (mm/dd/yy):